New insights into cellular prion protein (PrPc) functions: The "ying and yang" of a relevant protein

Brain Research Reviews

Volumn 61, Issue 2, 2009, Pages 170-184

  Nicolas, Oriol ^a,b   Gavín, Rosalina ^a,b   del Río, José A ^a,b  

^a INSTITUTE FOR BIOENGINEERING OF CATALONIA IBEC   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Cell death; Cell differentiation; Cell proliferation; Doppel; Prion; Shadoo

Indexed keywords

AMYLOID BETA PROTEIN; LIGAND; PRION PROTEIN; PROTEIN BAX; PROTEIN BCL 2;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; BRAIN FUNCTION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE COURSE; DISEASE MODEL; HOMEOSTASIS; HUMAN; MUTANT; NERVE CELL DEGENERATION; NONHUMAN; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ANIMALS; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; MICE; MICE, KNOCKOUT; PRION DISEASES; PRIONS; PRPC PROTEINS; SIGNAL TRANSDUCTION;

EID: 70349609866     PISSN: 01650173     EISSN: 18726321     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2009.06.002     Document Type: Review

References (200)

1. Aguib Y., et al. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc. Mol. Cell. Neurosci. 38 (2008) 98-109
2. Aguzzi A., and Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 116 (2004) 313-327
3. Aguzzi A., and Heikenwalder M. Pathogenesis of prion diseases: current status and future outlook. Nat. Rev., Microbiol. 4 (2006) 765-775
4. Aguzzi A., et al. Insights into prion strains and neurotoxicity. Nat. Rev., Mol. Cell Biol. 8 (2007) 552-561
5. Aguzzi A., et al. The prion's elusive reason for being. Annu. Rev. Neurosci. 31 (2008) 439-477
6. Aguzzi A., et al. Molecular mechanisms of prion pathogenesis. Annu. Rev. Pathol. 3 (2008) 11-40
7. Americo T.A., et al. Signaling induced by hop/STI-1 depends on endocytosis. Biochem. Biophys. Res. Commun. 358 (2007) 620-625
8. Anderson L., et al. Transgene-driven expression of the Doppel protein in Purkinje cells causes Purkinje cell degeneration and motor impairment. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3644-3649
9. Arruda-Carvalho M., et al. Hop/STI1 modulates retinal proliferation and cell death independent of PrPC. Biochem. Biophys. Res. Commun. 361 (2007) 474-480
10. Atarashi R., et al. Abnormal activation of glial cells in the brains of prion protein-deficient mice ectopically expressing prion protein-like protein, PrPLP/Dpl. Mol. Med. 7 (2001) 803-809
11. Baier M., et al. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development. Int. J. Dev. Neurosci. 26 (2008) 821-824
12. Bailly Y., et al. Prion protein (PrPc) immunocytochemistry and expression of the green fluorescent protein reporter gene under control of the bovine PrP gene promoter in the mouse brain. J. Comp. Neurol. 473 (2004) 244-269
13. Baker C.A., et al. Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles. J. Virol. 76 (2002) 10905-10913
14. Basler K., et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46 (1986) 417-428
15. Baumann F., et al. Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J. 26 (2007) 538-547
16. Beck J.A., et al. Association of a null allele of SPRN with variant Creutzfeldt-Jakob disease. J. Med. Genet. 45 (2008) 813-817
17. Behrens A., and Aguzzi A. Small is not beautiful: antagonizing functions for the prion protein PrP(C) and its homologue Dpl. Trends Neurosci. 25 (2002) 150-154
18. Behrens A., et al. Normal neurogenesis and scrapie pathogenesis in neural grafts lacking the prion protein homologue Doppel. EMBO Rep. 2 (2001) 347-352
19. Borchelt D.R., et al. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 267 (1992) 16188-16199
20. Brandner S., et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379 (1996) 339-343
21. Brandner S., et al. A crucial role for B cells in neuroinvasive scrapie. Transfus. Clin. Biol. 6 (1999) 17-23
22. Brown D.R. Prion protein peptides: optimal toxicity and peptide blockade of toxicity. Mol. Cell. Neurosci. 15 (2000) 66-78
23. Brown D.R., et al. The cellular prion protein binds copper in vivo. Nature 390 (1997) 684-687
24. Brown D.R., et al. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp. Neurol. 146 (1997) 104-112
25. Brown D.R., et al. Normal prion protein has an activity like that of superoxide dismutase. Biochem. J. 344 Pt. 1 (1999) 1-5
26. Brown D.R., et al. Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J. Neurosci. Res. 67 (2002) 211-224
27. Bruce M.E., et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389 (1997) 498-501
28. Bueler H., et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356 (1992) 577-582
29. Bueler H., et al. Mice devoid of PrP are resistant to scrapie. Cell 73 (1993) 1339-1347
30. Caetano F.A., et al. Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1. J. Neurosci. 28 (2008) 6691-6702
31. Cashman N.R., et al. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 61 (1990) 185-192
32. Checler F., and Vincent B. Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci. 25 (2002) 616-620
33. Cheng F., et al. Copper-dependent co-internalization of the prion protein and glypican-1. J. Neurochem. 98 (2006) 1445-1457
34. Chen S.G., et al. Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270 (1995) 19173-19180
35. Chesebro B., et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308 (2005) 1435-1439
36. Cheung E.C., et al. Apoptosis-inducing factor is a key factor in neuronal cell death propagated by BAX-dependent and BAX-independent mechanisms. J. Neurosci. 25 (2005) 1324-1334
37. Chiesa R., et al. Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 238-243
38. Cisse M.A., et al. The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J. Biol. Chem. 280 (2005) 40624-40631
39. Cohen E., and Taraboulos A. Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells. EMBO J. 22 (2003) 404-417
40. Collinge J., et al. Prion protein is necessary for normal synaptic function. Nature 370 (1994) 295-297
41. Collinge J., et al. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383 (1996) 685-690
42. Cregan S.P., et al. Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons. J. Neurosci. 19 (1999) 7860-7869
43. Criado J.R., et al. Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol. Dis. 19 (2005) 255-265
44. Curtis J., et al. Age-dependent loss of PTP and LTP in the hippocampus of PrP-null mice. Neurobiol. Dis. 13 (2003) 55-62
45. Debatin L., et al. Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease. Neurodegener. Dis. 5 (2008) 347-354
46. Depino A.M., et al. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease. Eur. J. Neurosci. 18 (2003) 2731-2742
47. Dong J., et al. Doppel induces degeneration of cerebellar Purkinje cells independently of Bax. Am. J. Pathol. 171 (2007) 599-607
48. Donne D.G., et al. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13452-13457
49. Edenhofer F., et al. Prion protein PrPc interacts with molecular chaperones of the Hsp60 family. J. Virol. 70 (1996) 4724-4728
50. Ferrer I., et al. Prion protein expression in senile plaques in Alzheimer's disease. Acta Neuropathol. 101 (2001) 49-56
51. Fioriti L., et al. The neurotoxicity of prion protein (PrP) peptide 106-126 is independent of the expression level of PrP and is not mediated by abnormal PrP species. Mol. Cell. Neurosci. 28 (2005) 165-176
52. Fischer M., et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15 (1996) 1255-1264
53. Flechsig E., et al. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 27 (2000) 399-408
54. Flechsig E., et al. Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia. EMBO J. 22 (2003) 3095-3101
55. Ford M.J., et al. Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience 113 (2002) 177-192
56. Forloni G., et al. Neurotoxicity of a prion protein fragment. Nature 362 (1993) 543-546
57. Fournier J.G., et al. Ultrastructural localization of cellular prion protein (PrPc) in synaptic boutons of normal hamster hippocampus. C. R. Acad. Sci., III 318 (1995) 339-344
58. Gabriel J.M., et al. Molecular cloning of a candidate chicken prion protein. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 9097-9101
59. Gauczynski S., et al. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20 (2001) 5863-5875
60. Gavin R., et al. PrP(106-126) activates neuronal intracellular kinases and Egr1 synthesis through activation of NADPH-oxidase independently of PrPc. FEBS Lett. 579 (2005) 4099-4106
61. Giese A., and Kretzschmar H.A. Prion-induced neuronal damage-the mechanisms of neuronal destruction in the subacute spongiform encephalopathies. Curr. Top. Microbiol. Immunol. 253 (2001) 203-217
62. Giese A., et al. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8 (1998) 449-457
63. Giri R.K., et al. Prion infection of mouse neurospheres. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3875-3880
64. Gougoumas D.D., et al. Transcriptional activation of prion protein gene in growth-arrested and differentiated mouse erythroleukemia and human neoplastic cells. Exp. Cell Res. 264 (2001) 408-417
65. Graner E., et al. Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res. Mol. Brain Res. 76 (2000) 85-92
66. Gray F., et al. Neuronal apoptosis in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 58 (1999) 321-328
67. Hachiya N.S., et al. Mitochondrial localization of cellular prion protein (PrPC) invokes neuronal apoptosis in aged transgenic mice overexpressing PrPC. Neurosci. Lett. 374 (2005) 98-103
68. Haigh C.L., et al. Copper binding is the governing determinant of prion protein turnover. Mol. Cell. Neurosci. 30 (2005) 186-196
69. Harris D.A., et al. Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry 32 (1993) 1009-1016
70. Hegde R.S., et al. A transmembrane form of the prion protein in neurodegenerative disease. Science 279 (1998) 827-834
71. Heitz S., et al. BAX contributes to Doppel-induced apoptosis of prion-protein-deficient Purkinje cells. Dev. Neurobiol. 67 (2007) 670-686
72. Heitz S., et al. BCL-2 counteracts Doppel-induced apoptosis of prion-protein-deficient Purkinje cells in the Ngsk Prnp(0/0) mouse. Dev. Neurobiol. 68 (2008) 332-348
73. Herms J.W., et al. Patch-clamp analysis of synaptic transmission to cerebellar purkinje cells of prion protein knockout mice. Eur. J. Neurosci. 7 (1995) 2508-2512
74. Herms J., et al. Evidence of presynaptic location and function of the prion protein. J. Neurosci. 19 (1999) 8866-8875
75. Hill A.F., et al. The same prion strain causes vCJD and BSE. Nature 389 (1997) 448-450 526
76. Holscher C., et al. Prion protein contains a second endoplasmic reticulum targeting signal sequence located at its C terminus. J. Biol. Chem. 276 (2001) 13388-13394
77. Hornemann S., and Glockshuber R. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6010-6014
78. Hornshaw M.P., et al. Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem. Biophys. Res. Commun. 207 (1995) 621-629
79. Hornshaw M.P., et al. Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem. Biophys. Res. Commun. 214 (1995) 993-999
80. Hutter G., et al. No superoxide dismutase activity of cellular prion protein in vivo. Biol. Chem. 384 (2003) 1279-1285
81. Kanaani J., et al. Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro. J. Neurochem. 95 (2005) 1373-1386
82. Katamine S., et al. Impaired motor coordination in mice lacking prion protein. Cell. Mol. Neurobiol. 18 (1998) 731-742
83. Khosravani H., et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J. Cell Biol. 181 (2008) 551-565
84. Khosravani H., et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J. Gen. Physiol. 131 (2008) i5
85. Kiachopoulos S., et al. Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation. Traffic 5 (2004) 426-436
86. Kikuchi Y., et al. G1-dependent prion protein expression in human glioblastoma cell line T98G. Biol. Pharm. Bull. 25 (2002) 728-733
87. Kim B.H., et al. A neuronal cell line that does not express either prion or doppel proteins. NeuroReport 16 (2005) 425-429
88. Kitamoto T., et al. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am. J. Pathol. 140 (1992) 1285-1294
89. Kniazeva M., et al. Expression of PrP mRNA is regulated by a fragment of MRP8 in human fibroblasts. Biochem. Biophys. Res. Commun. 234 (1997) 59-63
90. Kostic V., et al. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277 (1997) 559-562
91. Kunz B., et al. Neurotoxicity of prion peptide 106-126 not confirmed. FEBS Lett. 458 (1999) 65-68
92. Kurschner C., and Morgan J.I. The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res. Mol. Brain Res. 30 (1995) 165-168
93. Laine J., et al. Cellular and subcellular morphological localization of normal prion protein in rodent cerebellum. Eur. J. Neurosci. 14 (2001) 47-56
94. Lauren J., et al. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457 (2009) 1128-1132
95. Lee K.S., et al. Towards cellular receptors for prions. Rev. Med. Virol. 13 (2003) 399-408
96. Legname G., et al. Prion and doppel proteins bind to granule cells of the cerebellum. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 16285-16290
97. Li A., and Harris D.A. Mammalian prion protein suppresses Bax-induced cell death in yeast. J. Biol. Chem. 280 (2005) 17430-17434
98. Li R., et al. The expression and potential function of cellular prion protein in human lymphocytes. Cell. Immunol. 207 (2001) 49-58
99. Li A., et al. N-terminally deleted forms of the prion protein activate both Bax-dependent and Bax-independent neurotoxic pathways. J. Neurosci. 27 (2007) 852-859
100. Li A., et al. Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. EMBO J. 26 (2007) 548-558
101. Li A., et al. Prion protein with an octapeptide insertion has impaired neuroprotective activity in transgenic mice. EMBO J. 26 (2007) 2777-2785
102. Liang J., et al. Hypoxia induced overexpression of PrP(C) in gastric cancer cell lines. Cancer Biol. Ther. 6 (2007) 769-774
103. Linden R., et al. Physiology of the prion protein. Physiol. Rev. 88 (2008) 673-728
104. Lledo P.M., et al. Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2403-2407
105. Lopes M.H., et al. Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J. Neurosci. 25 (2005) 11330-11339
106. Luhrs T., et al. NMR structure of the human Doppel protein. J. Mol. Biol. 326 (2003) 1549-1557
107. Maglio L.E., et al. Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res. Mol. Brain Res. 131 (2004) 58-64
108. Maglio L.E., et al. Role of cellular prion protein on LTP expression in aged mice. Brain Res. 1097 (2006) 11-18
109. Ma J., and Lindquist S. De novo generation of a PrPSc-like conformation in living cells. Nat. Cell Biol. 1 (1999) 358-361
110. Mallucci G.R., et al. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J. 21 (2002) 202-210
111. Mallucci G., et al. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302 (2003) 871-874
112. Mallucci G.R., et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 53 (2007) 325-335
113. Manson J., et al. The prion protein gene: a role in mouse embryogenesis?. Development 115 (1992) 117-122
114. Manson J.C., et al. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8 (1994) 121-127
115. Marella M., and Chabry J. Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J. Neurosci. 24 (2004) 620-627
116. McGowan J.P. Scrapie in sheep. Scott. J. Agric. 5 (1922) 365-375
117. Miele G., et al. Embryonic activation and developmental expression of the murine prion protein gene. Gene Expr. 11 (2003) 1-12
118. Miller T.M., et al. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J. Cell Biol. 139 (1997) 205-217
119. Mironov Jr. A., et al. Cytosolic prion protein in neurons. J. Neurosci. 23 (2003) 7183-7193
120. Mo H., et al. Two different neurodegenerative diseases caused by proteins with similar structures. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2352-2357
121. Moore R.C., et al. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J. Mol. Biol. 292 (1999) 797-817
122. Moore R.C., et al. Doppel-induced cerebellar degeneration in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 15288-15293
123. Morel E., et al. The cellular prion protein PrP is involved in the proliferation of epithelial cells and in the distribution of junction-associated proteins. PLoS ONE 3 (2008) e3000
124. Moser M., et al. Developmental expression of the prion protein gene in glial cells. Neuronn. 14 (1995) 509-517
125. Mouillet-Richard S., et al. Prion protein and neuronal differentiation: quantitative analysis of prnp gene expression in a murine inducible neuroectodermal progenitor. Microbes Infect. 1 (1999) 969-976
126. Mouillet-Richard S., et al. Signal transduction through prion protein. Science 289 (2000) 1925-1928
127. Nicolas O., et al. Bcl-2 overexpression delays caspase-3 activation and rescues cerebellar degeneration in prion-deficient mice that overexpress amino-terminally truncated prion. FASEB J. 21 (2007) 3107-3117
128. Ott C.M., et al. Specific features of the prion protein transmembrane domain regulate nascent chain orientation. J. Biol. Chem. 282 (2007) 11163-11171
129. Pan K.M., et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10962-10966
130. Pan T., et al. Cell-surface prion protein interacts with glycosaminoglycans. Biochem. J. 368 (2002) 81-90
131. Pan T., et al. Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease. J. Virol. 79 (2005) 934-943
132. Parkin E.T., et al. Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 11062-11067
133. Pauly P.C., and Harris D.A. Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273 (1998) 33107-33110
134. Pimpinelli F., et al. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines. Eur. J. Neurosci. 21 (2005) 2063-2072
135. Premzl M., et al. Shadoo, a new protein highly conserved from fish to mammals and with similarity to prion protein. Gene 314 (2003) 89-102
136. Premzl M., et al. Evolution of vertebrate genes related to prion and Shadoo proteins-clues from comparative genomic analysis. Mol. Biol. Evol. 21 (2004) 2210-2231
137. Preusser M., et al. Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting. J. Neurol. Neurosurg. Psychiatry 77 (2006) 413-416
138. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 216 (1982) 136-144
139. Prusiner S.B. Molecular biology of prion diseases. Science 252 (1991) 1515-1522
140. Prusiner S.B. The prion diseases. Brain Pathol. 8 (1998) 499-513
141. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13363-13383
142. Puckett C., et al. Genomic structure of the human prion protein gene. Am. J. Hum. Genet. 49 (1991) 320-329
143. Radovanovic I., et al. Truncated prion protein and Doppel are myelinotoxic in the absence of oligodendrocytic PrPC. J. Neurosci. 25 (2005) 4879-4888
144. Raeber A.J., et al. Studies on prion replication in spleen. Dev. Immunol. 8 (2001) 291-304
145. Rambold A.S., et al. Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP. Mol. Biol. Cell 17 (2006) 3356-3368
146. Rambold A.S., et al. Stress-protective signalling of prion protein is corrupted by scrapie prions. EMBO J. 27 (2008) 1974-1984
147. Rangel A., et al. Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis, and death: role of AMPA/kainate receptors. J. Neurosci. Res. 85 (2007) 2741-2755
148. Re L., et al. Prion protein potentiates acetylcholine release at the neuromuscular junction. Pharmacol. Res. 53 (2006) 62-68
149. Rieger R., et al. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3 (1997) 1383-1388
150. Riek R., et al. NMR structure of the mouse prion protein domain PrP(121-321). Nature 382 (1996) 180-182
151. Riek R., et al. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 413 (1997) 282-288
152. Rivera-Milla E., et al. Disparate evolution of prion protein domains and the distinct origin of Doppel- and prion-related loci revealed by fish-to-mammal comparisons. FASEB J. 20 (2006) 317-319
153. Rossi D., et al. Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J. 20 (2001) 694-702
154. Sakaguchi S., et al. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380 (1996) 528-531
155. Sakudo A., et al. Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line. Biochem. Biophys. Res. Commun. 308 (2003) 660-667
156. Sales N., et al. Developmental expression of the cellular prion protein in elongating axons. Eur. J. Neurosci. 15 (2002) 1163-1177
157. Santuccione A., et al. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J. Cell Biol. 169 (2005) 341-354
158. Satoh J., et al. Gene expression profile in prion protein-deficient fibroblasts in culture. Am. J. Pathol. 157 (2000) 59-68
159. Schatzl H.M., et al. Prion protein gene variation among primates. J. Mol. Biol. 245 (1995) 362-374
160. Schmitt-Ulms G., et al. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J. Mol. Biol. 314 (2001) 1209-1225
161. Schultz J., et al. Role of interleukin-1 in prion disease-associated astrocyte activation. Am. J. Pathol. 165 (2004) 671-678
162. Schwarze-Eicker K., et al. Prion protein (PrPc) promotes beta-amyloid plaque formation. Neurobiol. Aging 26 (2005) 1177-1182
163. Shmerling D., et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93 (1998) 203-214
164. Shyng S.L., et al. Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. J. Biol. Chem. 270 (1995) 30221-30229
165. Silverman G.L., et al. Doppel is an N-glycosylated, glycosylphosphatidylinositol-anchored protein. Expression in testis and ectopic production in the brains of Prnp(0/0) mice predisposed to Purkinje cell loss. J. Biol. Chem. 275 (2000) 26834-26841
166. Simonic T., et al. cDNA cloning of turtle prion protein. FEBS Lett. 469 (2000) 33-38
167. Singh N., et al. Prion peptide 106-126 as a model for prion replication and neurotoxicity. Front. Biosci. 7 (2002) a60-71
168. Sorenson J.R. Prion diseases: copper deficiency states associated with impaired nitrogen monoxide or carbon monoxide transduction and translocation. J. Inorg. Biochem. 87 (2001) 125-127
169. Spielhaupter C., and Schatzl H.M. PrPC directly interacts with proteins involved in signaling pathways. J. Biol. Chem. 276 (2001) 44604-44612
170. Steele A.D., et al. Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3416-3421
171. Stewart R.S., et al. A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic reticulum. Mol. Biol. Cell 12 (2001) 881-889
172. Strumbo B., et al. Molecular cloning of the cDNA coding for Xenopus laevis prion protein. FEBS Lett. 508 (2001) 170-174
173. Sunyach C., et al. The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependent staurosporine-induced caspase-3 activation. J. Biol. Chem. 282 (2007) 1956-1963
174. Suzuki T., et al. cDNA sequence and tissue expression of Fugu rubripes prion protein-like: a candidate for the teleost orthologue of tetrapod PrPs. Biochem. Biophys. Res. Commun. 294 (2002) 912-917
175. Taylor D.R., and Hooper N.M. The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem. J. 402 (2007) 17-23
176. Tichopad A., et al. Tissue-specific expression pattern of bovine prion gene: quantification using real-time RT-PCR. Mol. Cell. Probes 17 (2003) 5-10
177. Tobler I., et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380 (1996) 639-642
178. Tsuchiya K., et al. Coexistence of CJD and Alzheimer's disease: an autopsy case showing typical clinical features of CJD. Neuropathology 24 (2004) 46-55
179. Vassallo N., and Herms J. Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J. Neurochem. 86 (2003) 538-544
180. Vincent B., et al. Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J. Biol. Chem. 275 (2000) 35612-35616
181. Vincent B., et al. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J. Biol. Chem. 276 (2001) 37743-37746
182. Waggoner D.J., et al. Brain copper content and cuproenzyme activity do not vary with prion protein expression level. J. Biol. Chem. 275 (2000) 7455-7458
183. Walz R., et al. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 40 (1999) 1679-1682
184. Walz R., et al. Cellular prion protein: implications in seizures and epilepsy. Cell. Mol. Neurobiol. 22 (2002) 249-257
185. Watt N.T., et al. Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J. Biol. Chem. 280 (2005) 35914-35921
186. Watts J.C., et al. The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections. EMBO J. 26 (2007) 4038-4050
187. Weissmann C., and Aguzzi A. Perspectives: neurobiology. PrP's double causes trouble. Science 286 (1999) 914-915
188. Wells G.A., et al. A novel progressive spongiform encephalopathy in cattle. Vet. Rec. 121 (1987) 419-420
189. Westaway D., et al. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell. 76 (1994) 117-129
190. Westergard L., et al. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim. Biophys. Acta 1772 (2007) 629-644
191. Wong C., et al. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. EMBO J. 20 (2001) 377-386
192. Wopfner F., et al. Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J. Mol. Biol. 289 (1999) 1163-1178
193. Yamaguchi N., et al. Doppel-induced Purkinje cell death is stoichiometrically abrogated by prion protein. Biochem. Biophys. Res. Commun. 319 (2004) 1247-1252
194. Yehiely F., et al. Identification of candidate proteins binding to prion protein. Neurobiol. Dis. 3 (1997) 339-355
195. Yin S., et al. Prion proteins with insertion mutations have altered N-terminal conformation and increased ligand binding activity and are more susceptible to oxidative attack. J. Biol. Chem. 281 (2006) 10698-10705
196. Yost C.S., et al. Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein. Nature 343 (1990) 669-672
197. Zanata S.M., et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21 (2002) 3307-3316
198. Zeng F., et al. Tethering the N-terminus of the prion protein compromises the cellular response to oxidative stress. J. Neurochem. 84 (2003) 480-490
199. Zhang C.C., et al. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2184-2189
200. Zhu Y., et al. p38 Mitogen-activated protein kinase mediates hypoxic regulation of Mdm2 and p53 in neurons. J. Biol. Chem. 277 (2002) 22909-22914